There are significant implications to the to the potential rescheduling of cannabis by the U.S. Drug Enforcement Administration (DEA). The DEA announced on April 30 that it would begin the rulemaking process to reschedule cannabis to align with the Department of Health and Human Series (HHS) recommendations.
Industry-wide, there has been rampant speculation about what the policy move will mean for various segments of the pan-cannabis sector. Even though hemp is separately defined and theoretically discrete from recreational and medical MJ, there are some potential benefits for these operators.
…
12.27.2024
US RD, SAF supplies remain strong despite declining import volumes
US supplies of sustainable aviation fuel (SAF) fell sharply in November but reached the highest November volume on record, according to data released on Thursday December 26 by the...
12.27.2024
Animal fats and oils end week steady amid holiday-limited trades
The US animal fats and oils markets held steady on Friday December 27, with limited trades persisting due to the holiday season.
Weekly averages were unchanged from the prior week...
12.27.2024
Relative prices of US meat and bonemeal rise amid depressed soybean meal market: 2024 recap
US animal protein prices were steady to lower on Friday December 27. Some participants reported distressed loads in the market late in the afternoon of Thursday December 26 and...